Position history for HARDING LOEVNER LP's holdings in VERTEX PHARMACEUTICALS INC
HARDING LOEVNER LP holds 391,865 shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $177.7M as of 2025-Q4. The position was decreased (-14.1% shares). VRTX represents 1.6% of HARDING LOEVNER LP's portfolio.
Current Value
$177.7M
Current Shares
391,865
Total Value Change
-$377.5M
Total Shares Change
-792,543
Other major holders of VRTX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Decreased |
| 391,865 |
-14.1% |
| $177.7M |
| 1.6% |
| $453.74 |
0 |
| 2025-Q3 | Decreased | 455,988 | -35.9% | $178.6M | 1.3% | $395.31 | 0 |
| 2025-Q2 | Increased | 711,611 | +1.9% | $316.8M | 2.1% | $441.30 | 54 |
| 2025-Q1 | Decreased | 698,459 | -15.2% | $338.6M | 2.6% | $492.69 | 0 |
| 2024-Q4 | Decreased | 823,627 | -28.5% | $331.7M | 2.2% | $399.35 | 0 |
| 2024-Q3 | Decreased | 1.2M | -2.7% | $536.1M | 3.1% | $462.88 | 0 |
| 2024-Q2 | Decreased | 1.2M | -3.2% | $555.2M | 3.1% | $468.72 | 0 |